Molecular Design: Semaglutide is a modified human GLP-1 analog, similar to liraglutide in structure but with a few differences
In the ATTAIN-2 trial (participants with obesity and type 2 diabetes), GI adverse event rates were somewhat higher than in ATTAIN-1: nausea 20.1-36.4% versus 8.4% with placebo, vomiting 12.8-23.1% versus 3.8%, diarrhea 21.3-27.4% versus 15.0%, and constipation 17.7-22.4% versus 7.8%
Wilcken, B
Its capsule form makes it incredibly easy to take, and it contains no unnecessary fillers or additives, appealing to users who want a clean supplement
containing 10 mg of mHSA) in PBS at pH 7.4
Cada 1 dose (2 cpsulas) contm: Acetil L-carnitina 500mg cido Alfa Lipico 200mg Excipiente* q.s.p 1 dose *amido, talco, dixido de silcio, estearato de magnsio Tomar 1 dose (2 cpsulas) 2 vezes ao dia